|Clonal evolution in breast cancer revealed by single nucleus genome sequencing|
Y Wang, J Waters, ML Leung, A Unruh, W Roh, X Shi, K Chen, P Scheet, ...
Nature 512 (7513), 155-160, 2014
|Dynamics of chronic myeloid leukaemia|
F Michor, TP Hughes, Y Iwasa, S Branford, NP Shah, CL Sawyers, ...
Nature 435 (7046), 1267-1270, 2005
|The mathematics of cancer: integrating quantitative models|
PM Altrock, LL Liu, F Michor
Nature Reviews Cancer 15 (12), 730-745, 2015
|Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity|
A Marusyk, DP Tabassum, PM Altrock, V Almendro, F Michor, K Polyak
Nature 514 (7520), 54-58, 2014
|Dynamics of cancer progression|
F Michor, Y Iwasa, MA Nowak
Nature reviews cancer 4 (3), 197-205, 2004
|Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling|
J Chmielecki, J Foo, GR Oxnard, K Hutchinson, K Ohashi, R Somwar, ...
Science translational medicine 3 (90), 90ra59-90ra59, 2011
|Epidermal growth factor receptor tyrosine kinase inhibitor–resistant disease|
K Ohashi, YE Maruvka, F Michor, W Pao
Journal of Clinical Oncology 31 (8), 1070, 2013
|Studying clonal dynamics in response to cancer therapy using high-complexity barcoding|
HC Bhang, DA Ruddy, V Krishnamurthy Radhakrishna, JX Caushi, ...
Nature medicine 21 (5), 440-448, 2015
|Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies|
H Haeno, M Gonen, MB Davis, JM Herman, CA Iacobuzio-Donahue, ...
Cell 148 (1-2), 362-375, 2012
|Polyploidy can drive rapid adaptation in yeast|
AM Selmecki, YE Maruvka, PA Richmond, M Guillet, N Shoresh, ...
Nature 519 (7543), 349-352, 2015
|Punctuated copy number evolution and clonal stasis in triple-negative breast cancer|
R Gao, A Davis, TO McDonald, E Sei, X Shi, Y Wang, PC Tsai, ...
Nature genetics 48 (10), 1119-1130, 2016
|A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia|
A Klinakis, C Lobry, O Abdel-Wahab, P Oh, H Haeno, S Buonamici, ...
Nature 473 (7346), 230-233, 2011
|Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma|
T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ...
Cancer cell 26 (2), 288-300, 2014
|Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype|
SY Park, M Gönen, HJ Kim, F Michor, K Polyak
The Journal of clinical investigation 120 (2), 636-644, 2010
|Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma|
CJ Gibson, RC Lindsley, V Tchekmedyian, BG Mar, J Shi, S Jaiswal, ...
Journal of Clinical Oncology 35 (14), 1598, 2017
|Synergy and discounting of cooperation in social dilemmas|
C Hauert, F Michor, MA Nowak, M Doebeli
Journal of theoretical biology 239 (2), 195-202, 2006
|Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq|
M Karaayvaz, S Cristea, SM Gillespie, AP Patel, R Mylvaganam, CC Luo, ...
Nature communications 9 (1), 3588, 2018
|Successful therapy must eradicate cancer stem cells|
D Dingli, F Michor
Stem cells 24 (12), 2603-2610, 2006
|Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response|
NA Jones, X Wei, DR Flower, ML Wong, F Michor, MS Saag, BH Hahn, ...
The Journal of experimental medicine 200 (10), 1243-1256, 2004
|Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity|
V Almendro, YK Cheng, A Randles, S Itzkovitz, A Marusyk, E Ametller, ...
Cell reports 6 (3), 514-527, 2014